These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32524588)

  • 1. Epidermolysis Bullosa Pruriginosa successfully treated with concomitant topical and systemic agents.
    Ferreira S; Azevedo A; Velho GC; Sanches M; Selores M
    Australas J Dermatol; 2020 Nov; 61(4):355-357. PubMed ID: 32524588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermolysis bullosa pruriginosa treated with dupilumab.
    Zhou AG; Little AJ; Antaya RJ
    Pediatr Dermatol; 2021 Mar; 38(2):526-527. PubMed ID: 33336814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of tofacitinib in epidermolysis bullosa pruriginosa.
    Chen KJ; Fang S; Ye Q; Jia M
    Clin Exp Dermatol; 2022 Mar; 47(3):598-600. PubMed ID: 34699628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features.
    McGrath JA; Schofield OM; Eady RA
    Br J Dermatol; 1994 May; 130(5):617-25. PubMed ID: 8204470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermolysis bullosa pruriginosa--report of three cases.
    Das JK; Sengupta S; Gangopadhyay AK
    Indian J Dermatol Venereol Leprol; 2005; 71(2):109-11. PubMed ID: 16394385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermolysis bullosa pruriginosa: A rare entity which responded well to thalidomide.
    Rani S; Gupta A; Bhardwaj M
    Dermatol Ther; 2019 Sep; 32(5):e13035. PubMed ID: 31355515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermolysis Bullosa Pruriginosa: Case Series and Review of the Literature.
    Kim WB; Alavi A; Pope E; Walsh S
    Int J Low Extrem Wounds; 2015 Jun; 14(2):196-9. PubMed ID: 25694436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pruritus Anesis in Dystrophic Epidermolysis Bullosa Pruriginosa with Dupilumab.
    Yang DY; Jing WW; Liu X; Li L; Lu T; Li XL
    Adv Skin Wound Care; 2024 Feb; 37(2):1-4. PubMed ID: 38241457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of epidermolysis bullosa pruriginosa by dupilumab.
    Wu XG; Yan S; Jiang JQ; Zhou TT; Fang X; Yang H; Bai XM; Wang H; Luo X
    J Dermatol; 2023 Jun; 50(6):837-842. PubMed ID: 36694424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermolysis bullosa pruriginosa masquerading as psychogenic pruritus.
    Tey HL; Lee AD; Almaani N; McGrath JA; Mills KC; Yosipovitch G
    Arch Dermatol; 2011 Aug; 147(8):956-60. PubMed ID: 21844455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermolysis bullosa pruriginosa in association with lichen planopilaris.
    Almaani N; Liu L; Perez A; Robson A; Mellerio JE; McGrath JA
    Clin Exp Dermatol; 2009 Dec; 34(8):e825-8. PubMed ID: 20055845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of epidermolysis bullosa pruriginosa using systemic and topical agents.
    Mangold AR; Cole CM; DiCaudo DJ; Pittelkow MR; Sekulic A
    J Am Acad Dermatol; 2014 Jun; 70(6):e136-7. PubMed ID: 24831336
    [No Abstract]   [Full Text] [Related]  

  • 13. Dominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment.
    Pallesen KAU; Lindahl KH; Bygum A
    Acta Derm Venereol; 2019 Nov; 99(12):1195-1196. PubMed ID: 31453628
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of epidermolysis bullosa pruriginosa-associated pruritus with dupilumab.
    Shehadeh W; Sarig O; Bar J; Sprecher E; Samuelov L
    Br J Dermatol; 2020 Jun; 182(6):1495-1497. PubMed ID: 31899820
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidermolysis bullosa pruriginosa (McGrath) successfully controlled by oral cyclosporin.
    Yamasaki H; Tada J; Yoshioka T; Arata J
    Br J Dermatol; 1997 Aug; 137(2):308-10. PubMed ID: 9292092
    [No Abstract]   [Full Text] [Related]  

  • 16. Thalidomide in the management of epidermolysis bullosa pruriginosa.
    Ozanic Bulic S; Fassihi H; Mellerio JE; McGrath JA; Atherton DJ
    Br J Dermatol; 2005 Jun; 152(6):1332-4. PubMed ID: 15949003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel splice site mutation in collagen type VII gene in a Chinese family with dominant dystrophic epidermolysis bullosa pruriginosa.
    Jiang W; Bu D; Yang Y; Zhu X
    Acta Derm Venereol; 2002; 82(3):187-91. PubMed ID: 12353709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.
    Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç
    J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel de novo splice-site mutation in the COL7A1 gene in dominant dystrophic epidermolysis bullosa (DDEB): specific exon skipping could be a prognostic factor for DDEB pruriginosa.
    Saito M; Masunaga T; Ishiko A
    Clin Exp Dermatol; 2009 Dec; 34(8):e934-6. PubMed ID: 19486058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Control of Recalcitrant Pruritus in Epidermolysis Bullosa Pruriginosa With Dupilumab.
    Roque Quintana B; Piqué Durán E; Pérez Cejudo JA
    Actas Dermosifiliogr; 2024 Feb; 115(2):184-186. PubMed ID: 36871818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.